The effect of intravenous contrast on intensity-modulated radiation therapy dose calculations for head and neck cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 28, Issue 5, 2005, Pages 456-459

  Liauw, Stanley L ^a   Amdur, Robert J ^a   Mendenhall, William M ^a   Palta, Jatinder ^a   Kim, Siyong ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Head and neck; IMRT; Intravenous contrast; Radiotherapy; Treatment planning

Indexed keywords

CONTRAST MEDIUM; IOHEXOL;

ARTICLE; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DOSIMETRY; DRUG EFFECT; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION RESPONSE; TONGUE CANCER; TREATMENT PLANNING;

CONTRAST MEDIA; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRAVENOUS; RADIOTHERAPY DOSAGE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 26444487270     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000170796.89560.02     Document Type: Article

References (3)

1. International Commission on Radiation Units and Measurements. Report 62: Prescribing, Recording, and Reporting Photon Beam Therapy (supplement to ICRU Report 50). Bethesda, MD; 1999.
2. Ramm U, Dmarau M, Mose S, et al. Influence of CT contrast agents on dose calculations in a 3D treatment planning system. Phys Med Biol. 2001;46:2631-2635.
3. Khan FM. Interactions of Ionizing Radiation. The Physics of Radiation Therapy, ed 3. Philadelphia: Lippincott Williams & Wilkins; 2003:59-77.